Speaker illustration

Professor Ulrich Laufs

University hospital Leipzig AoR, Leipzig (Germany)

Member of:

Ulrich Laufs is Chair and Professor of Cardiology at Leipzig University, Germany. After completing his training at the University of Hamburg, he served a residency at the University of Cologne and spent 2 years as post-doctoral researcher at the Brigham and Women’s Hospital in Boston, USA. Before moving to Leipzig in 2017, he was Vice-chairman of the Department of Internal Medicine, Cardiology, Angiology and Intensive Medicine at the University of Saarland in Homburg, Germany. Professor Laufs has published multiple experimental and clinical studies in the areas of ‘heart failure’, ‘heart and brain’ and ‘prevention’ with special interest in lipoprotein metabolism. He has received numerous honours, serves in several editorial boards of international cardiovascular journals and holds positions in cardiovascular societies.

Statin therapy: clinical role and current challenges

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session type: Moderated ePosters

Thumbnail

Great Debate: controversy – do patients benefit from omega-3 fatty acids?

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session type: Great Debates

Thumbnail

Congress committee e-posters choice in preventive cardiology and special populations

Event: ESC Congress 2021 - The Digital Experience

Topic: Rehabilitation and Sports Cardiology

Session type: Congress Committee e-posters Choice

Thumbnail

Evolving concepts in lipidology

Event: ESC CONGRESS 2019

Topic: Drug therapy

Session type: Symposium

Thumbnail

Lipid modification for the 21st century

Event: ESC CONGRESS 2019

Topic: Lipids

Session type: Advances in Science

Thumbnail

How good/bad are we in treating lipids

Event: ESC CONGRESS 2019

Topic: Lipids

Session type: Moderated Posters

Thumbnail

Optimising cardiovascular outcomes with PCSK9 inhibitors: start now before a potential next MI or stroke!

Event: ESC Congress 2018

Topic: Clinical Skills

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Meet the trialist - ARRIVE - Aspirin to Reduce Risk of Initial Vascular Events

Event: ESC Congress 2018

Topic: Prevention

Session type: Late-Breaking Science

Thumbnail

Optimising cardiovascular outcomes with PCSK9 inhibitors: start now before a potential next MI or stroke!

Event: ESC Congress 2018

Topic: Clinical Skills

Session type: Satellite Symposium

Thumbnail

LDL-c: done deal, next epigenetics? (EBAC Accredited)

Event: ESC Congress 2018

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk